Showing results (1691-1700 of 1,878) with videos related to
Sort By:
Pageof 188
Military Medicine|November 22, 2025
Lower Extremity Symmetry and Normative Values During Functional Performance Tests in Entry-Level U.S. MarinesAmelia S Bruce Leicht, Joshua D Winters, Reiley T Bergin, et al.Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|October 31, 2022
Predictors of humoral response to SARS-CoV-2 mRNA vaccine BNT162b2 in patients receiving maintenance dialysisTingting Li, Sumanth Gandra, Kimberly A Reske, et al.Journal of the American Chemical Society|March 4, 2011
Mechanically stabilized tetrathiafulvalene radical dimersAli Coskun, Jason M Spruell, Gokhan Barin, et al.Ophthalmology|March 12, 2013
Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2Francesco Testa, Albert M Maguire, Settimio Rossi, et al.Journal of the American Chemical Society|February 28, 2015
Ultrahigh surface area zirconium MOFs and insights into the applicability of the BET theoryTimothy C Wang, Wojciech Bury, Diego A Gómez-Gualdrón, et al.Hypertension (Dallas, Tex. : 1979)|December 11, 2013
Validation of uromodulin as a candidate gene for human essential hypertensionLesley A Graham, Sandosh Padmanabhan, Niall J Fraser, et al.ACS Medicinal Chemistry Letters|September 17, 2025
Discovery of Novel Isofunctional SARS-CoV‑2 NSP14 RNA Cap Methyltransferase Inhibitors by Structure-Based Virtual ScreeningCindy Meyer, Mayako Michino, David J Huggins, et al.Journal of the American Chemical Society|April 1, 2020
Highly Stable Organic Bisradicals Protected by Mechanical BondsKang Cai, Haochuan Mao, Wei-Guang Liu, et al.Science (New York, N.Y.)|June 13, 2020
A precise polyrotaxane synthesizerYunyan Qiu, Bo Song, Cristian Pezzato, et al.Antimicrobial Agents and Chemotherapy|August 18, 2025
Cytomegalovirus prophylaxis with letermovir in pediatric (birth to <18 years of age) hematopoietic cell transplant recipients: pharmacokinetics, efficacy, and safety results of a Phase 2b studyAndreas H Groll, Lara Danziger-Isakov, Aharon Gefen, et al.Pageof 188